MANALAPAN, N.J. and NEW YORK, April 8, 2011 (GLOBE NEWSWIRE) -- Anslow + Jaclin, LLP, announced today that it has hired Thomas R. Slusarczyk as a senior attorney in the law firm.
"We are pleased to have Tom join Anslow + Jaclin, LLP. Tom brings to us a valuable mix of large law firm training and discipline combined with a proactive approach to practicing law," stated Managing Partner Richard Anslow. "His 10 years of experience with DLA Piper LLP, New York, Deutsche Bank AG, New York, and General Electric Healthcare, combined with his ability to understand and provide a solution for a client's particular need, makes Tom a key component in our continued growth within our industry."
"Tom's technical skills and knowledge are second-to-none. From the simplest regulatory question to the most complex of capital raising solutions, Tom has proven himself an incredibly able and effective resource for Anslow + Jaclin's clients," added Partner Gregg Jaclin.
About Thomas R. Slusarczyk, Esq.
Thomas Slusarczyk is a securities and corporate lawyer who represents public and private companies with securities matters (including, SEC registration statement filings, IPOs, reverse mergers, private investment in public equity (PIPE) transactions, rights offerings, Regulation D and S offerings, Sarbanes-Oxley compliance and blue sky filings), mergers & acquisitions, joint ventures, dispositions, and general corporate matters. Mr. Slusarczyk also advises public companies (both foreign and domestic) regarding compliance with its 1934 Exchange Act requirements, including all periodic filings on Forms 10-K, 10-Q and 8-K (Forms 20-F and 6-K for foreign private issuers), and proxy statements, as well as, other regulatory and other filing requirements with the SEC, NYSE, NASDAQ, NYSE AMEX and FINRA.
Prior to joining Anslow + Jaclin, Mr. Slusarczyk represented clients in corporate and securities matters for the law firm DLA Piper LLP in New York. He was also in-house corporate development counsel for Deutsche Bank AG in New York, advising on M&A transactions for the global bank. Mr. Slusarczyk has also represented General Electric Healthcare on healthcare compliance matters, including FDA compliance, advising on the AdvaMed Code of Ethics, the Anti-kickback Statute and Stark Law compliance.
Mr. Slusarczyk obtained a B.S. degree in engineering from Western Michigan University and his Juris Doctor from Syracuse University College of Law, where he was an editor on the Syracuse Law Review. He is a member of the New York state bar.
About Anslow + Jaclin, LLP
Anslow + Jaclin serves diverse clients worldwide (including China, India, Canada and Europe) on unique and sophisticated securities and corporate matters including IPOs, PIPEs, reverse mergers, corporate finance and M+A. Anslow + Jaclin's global clients are publicly held corporations which include well-established companies, emerging and development stage companies, entrepreneurial start-up enterprises and other business entities across a broad range of industries. Anslow + Jaclin has consistently been ranked as one of the top (ranked 1st in 2008 and 2009 and ranked 3rd in 2010) law firms in the United States by SEC New Registrations Report for the number of pre-effective IPO registrations advised. In addition, Deal Flow Media, Inc.'s The PIPEs Report ranks Anslow + Jaclin as one of the top 10 Issuers and Investors Legal Counsel for number of placements advised.
The Anslow + Jaclin, LLP logo is available at
CONTACT: Anslow + Jaclin, LLP Thomas R. Slusarczyk, Esq. Tel. : (732) 409-1212 x204 Fax. : (732) 577-1188 TSlusarczyk@anslowlaw.com www.anslowlaw.com